Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Eye for the prize

Article Abstract:

Onex Corp CEO Gerald Schwartz, who has built his career through lucrative corporate takeovers, is the key figure behind Onex's $2.3 billion buyout offer for the diversified Canadian brewing firm John Labatt Ltd. Onex's debt-financed takeovers typically result in liquidation of acquired assets.

Author: Willis, Andrew
Publisher: Rogers Publishing Ltd.
Publication Name: Maclean's
Subject: News, opinion and commentary
ISSN: 0024-9262
Year: 1995
Officials and employees, Investments, Holding companies, Biography, Schwartz, Gerald

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The winning brew

Article Abstract:

Belgium's Interbrew has made a strong bid to acquire John Labatt Ltd, which has been fighting a hostile takeover offer from Onex Corp. Interbrew plans to sell of many of Labatt's non-brewing assets, such as The Sports Network and its minority stake in Toronto's SkyDome stadium complex.

Author: Willis, Andrew
Publisher: Rogers Publishing Ltd.
Publication Name: Maclean's
Subject: News, opinion and commentary
ISSN: 0024-9262
Year: 1995
Interbrew S.A.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Mergers, acquisitions and divestments, Brewing industry, Breweries, Onex Corp., John Labatt Ltd.
Similar abstracts:
  • Abstracts: Chair trigger. The sporting life
  • Abstracts: Lord of the flies. Death defying
  • Abstracts: Fair crack of the quip. The meal deal
  • Abstracts: Lessons from Ontario. The Ottawa handicap. Governing in the slow lane: the Liberals continue to drag their heels on some painful policy choices
  • Abstracts: Tenor of the times: the Vancouver Opera soars with a star singer. East End vs. West Side: two Vancouver boys face off in a heated contest of class and styles
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.